Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis.
Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis.
Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study.
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis.
The Influence of T Cell Ig Mucin-3 Signaling on Central Nervous System Autoimmune Disease Is Determined by the Effector Function of the Pathogenic T Cells.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
The best clinical paper on multiple sclerosis in 2012: Commentary.
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
Pages
« first
‹ previous
…
500
501
502
503
504
505
506
507
508
…
next ›
last »